chronic kidney disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. According to the 2001 KDIGO guideline CKD3 diagnostic criteria 30 < eGFR < 59ml/min.1.73m2, and according to the 2002 edition of the guidelines for clinical research on the treatment of chronic renal failure by Chinese medicine new drug, the TCM syndrome differentiation is spleen-kidney qi deficiency accompanied by stasis syndrome; 2. Electrolyte disorders and hypertension were effectively controlled, and no other traditional Chinese medicine or proprietary Chinese medicine was taken during the treatment; 3. Men and women older than 18 years; 4. Agree to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women and women who plan to become pregnant 2. Screening patients who had received other research drugs in the first 3 months 3. Patients who are known to be allergic to or unable to tolerate certain drugs in the study 4. Active liver disease, or abnormal liver function, myocardial infarction, or stroke, or congestive heart failure 5. The researchers considered it unsuitable for the study's patients 6. With history of serious illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CREATINE; | — |
Countries
China
Contacts
Shenzhen Traditional Chinese Medicine Hospital